Login / Signup

Cagrilintide is not associated with clinically relevant QTc prolongation: A thorough QT study in healthy participants.

Maria Buur Nordskov GabeRainard FuhrAngela SinnAstrid EliasenKasper K BerthelsenAnja B KuhlmanTine A BaekdalAyna B Nejad
Published in: Diabetes, obesity & metabolism (2024)
Cagrilintide did not result in clinically relevant QTcF prolongation, indicating no increased risk of ventricular tachyarrhythmias.
Keyphrases
  • drug induced
  • heart failure
  • left ventricular
  • atrial fibrillation